Inhaled iloprost in pulmonary arterial hypertension (Q30437211)

21 June 2017

1 reference

title

Inhaled iloprost in pulmonary arterial hypertension (English)

1 reference

21 June 2017

arterial hypertension

1 reference

Stacey E Baker

1

1 reference

PubMed ID

15976392

21 June 2017

Rebecca Haynes Hockman

series ordinal

2

1 reference

PubMed ID

15976392

21 June 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Annals of Pharmacotherapy

21 June 2017

1 reference

21 June 2017

39

1 reference

21 June 2017

7-8

1 reference

21 June 2017

1265-1274

1 reference

Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 June 2017

1 reference

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

Inhaled iloprost: in primary pulmonary hypertension

21 January 2018

1 reference

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin

21 January 2018

1 reference

Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension

21 January 2018

1 reference

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation

21 January 2018

1 reference

Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.

21 January 2018

1 reference

Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.

21 January 2018

1 reference

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

21 January 2018

1 reference

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

21 January 2018

1 reference

Long-term treatment of pulmonary hypertension with aerosolized iloprost

21 January 2018

1 reference

Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise

21 January 2018

1 reference

Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.

21 January 2018

1 reference

Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension

21 January 2018

1 reference

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension

21 January 2018

1 reference

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment

21 January 2018

1 reference

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

21 January 2018

1 reference

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension

21 January 2018

1 reference

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

21 January 2018

1 reference

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

21 January 2018

1 reference

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

21 January 2018

1 reference

Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance

21 January 2018

1 reference

First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance

21 January 2018

1 reference

Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension

21 January 2018

1 reference

Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost.

21 January 2018

1 reference

Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass

21 January 2018

1 reference

Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension

21 January 2018

1 reference

Long-time survival with HIV-related pulmonary arterial hypertension: a case report

21 January 2018

1 reference

Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension.

21 January 2018

1 reference

Treatment of severe pulmonary hypertension with inhaled iloprost

21 January 2018

1 reference

Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion

21 January 2018

1 reference

New combined treatments avoided transplantation in a child with severe pulmonary hypertension

21 January 2018

1 reference

Paradoxical increase of pulmonary vascular resistance during testing of inhaled iloprost

21 January 2018

1 reference

Use of inhaled iloprost in a case of pulmonary hypertension during pediatric congenital heart surgery

21 January 2018

1 reference

Aerosolized iloprost for severe pulmonary hypertension as a bridge to heart transplantation

21 January 2018

1 reference

Impact of aerosolized prostacyclin analog for severe pulmonary hypertension in thoracic organ transplantation

21 January 2018

1 reference

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms

21 January 2018

1 reference

Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.

21 January 2018

1 reference

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

Methodology and grading for pulmonary hypertension evidence review and guideline development.

21 January 2018

1 reference

Treatment of pulmonary arterial hypertension: a preliminary decision analysis

21 January 2018

1 reference

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E575

1 reference

21 June 2017

1 reference

PubMed ID

15976392